Article

External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older.

Division of General Medicine and Primary Care, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Journal of the American Geriatrics Society (impact factor: 3.74). 08/2011; 59(8):1444-51. DOI:10.1111/j.1532-5415.2011.03523.x pp.1444-51
Source: PubMed

ABSTRACT To further validate an index predicting mortality in community-dwelling older adults.
A comparison of the performance of the index in predicting mortality among new respondents to the National Health Interview Survey (NHIS, 2001-2004) with that of respondents from the original development and validation cohorts (1997-2000) and a test of its performance over extended follow-up (up to 9 years) using the original cohorts. Follow-up mortality data were available through 2006.
NHIS.
Twenty-two thousand fifty-seven new respondents to the NHIS (2001-2004) and 24,139 respondents from the original development and validation cohorts (1997-2000).
A risk score was calculated for each respondent based on the presence or absence of 11 factors (function, illnesses, behaviors, demographics) that make up the index. Using the Kaplan-Meier method, 5-year mortality estimates were computed for the new and original cohort respondents and 9-year mortality estimates for the original cohorts.
New respondents were similar to original cohort respondents but were slightly more likely to be aged 85 and older, report diabetes mellitus, and have a body mass index of 25.0 kg/m² or greater. The model performed as well in the new cohort as it had in the original cohort. New respondents with risk scores of 0 to 1 had a 2% risk of 5-year mortality, whereas respondents who scored 18 or higher had a 69% risk of 5-year mortality (range 3-71% risk of 5-year mortality in the development cohort). The index also demonstrated excellent calibration and discrimination in predicting 9-year mortality (range 7% risk for scores of 0-1 to 92% risk for scores of ≥ 18, original validation cohort extended).
These results further justify use of this index to estimate life expectancy in clinical decision-making.

0 0
 · 
0 Bookmarks
 · 
37 Views
  • Source
    Article: Older adults' attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities.
    Carmen L Lewis, Christine E Kistler, Halle R Amick, Lea C Watson, Debra L Bynum, Louise C Walter, Michael P Pignone
    [show abstract] [hide abstract]
    ABSTRACT: Individualized decision making has been recommended for cancer screening decisions in older adults. Because older adults' preferences are central to individualized decisions, we assessed older adults' perspectives about continuing cancer screening later in life. Face to face interviews with 116 residents age 70 or over from two long-term care retirement communities. Interview content included questions about whether participants had discussed cancer screening with their physicians since turning age 70, their attitudes about information important for individualized decisions, and their attitudes about continuing cancer screening later in life. Forty-nine percent of participants reported that they had an opportunity to discuss cancer screening with their physician since turning age 70; 89% would have preferred to have had these discussions. Sixty-two percent believed their own life expectancy was not important for decision making, and 48% preferred not to discuss life expectancy. Attitudes about continuing cancer screening were favorable. Most participants reported that they would continue screening throughout their lives and 43% would consider getting screened even if their doctors recommended against it. Only 13% thought that they would not live long enough to benefit from cancer screening tests. Factors important to consider stopping include: age, deteriorating or poor health, concerns about the effectiveness of the tests, and doctors recommendations. This select group of older adults held positive attitudes about continuing cancer screening later in life, and many may have had unrealistic expectations. Individualized decision making could help clarify how life expectancy affects the potential survival benefits of cancer screening. Future research is needed to determine whether educating older adults about the importance of longevity in screening decisions would be acceptable, affect older adults' attitudes about screening, or change their screening behavior.
    BMC Geriatrics 02/2006; 6:10. · 2.34 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

11 factors
 
5-year mortality
 
5-year mortality estimates
 
9-year mortality
 
9-year mortality estimates
 
body mass index
 
community-dwelling older adults
 
estimate life expectancy
 
Follow-up mortality data
 
National Health Interview Survey
 
new respondents
 
original cohort respondents
 
original cohorts
 
original validation cohort extended
 
range 7% risk
 
report diabetes mellitus
 
risk score
 
risk scores
 
thousand fifty-seven new respondents
 
validation cohorts